University at Buffalo (UB)
Lucy D. Mastrandrea MD, PhD
Lucy D. Mastrandrea
MD, PhD
Professor; Division Chief, Endocrinology/Diabetes
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Endocrinology; Pathophysiology; Pediatric Diabetes; Pediatric Endocrinology; Pediatrics
Contact Information
Patient Care
Patient Care
This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.
View this physician on UBMDEducation and Training:
- Fellowship, Pediatric Endocrinology, University at Buffalo (2005)
- Residency, Pediatrics, University at Buffalo (2001)
- Internship, Pediatrics, University at Buffalo (2000)
- MD, Medicine, University at Buffalo (1999)
- PhD, Biochemistry, University at Buffalo (1999)
- BS, Biochemistry, Manhattan College, Summa Cum Laude (1990)
Employment:
- Medical Director, Diabetes Center, Oishei Childrens Hospital (2017-present)
- Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2022-present)
- Division Chief, Endocrinology/Diabetes, UBMD Pediatrics (2017-present)
- Medical Director, Diabetes Center, Oishei Children‘s Hospital (2017-present)
- Associate Fellowship Program Director, Endocrinology/Diabetes, University at Buffalo (2011-present)
- Adjunct Research Assistant Professor, Pharmacology and Toxicology, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2008-present)
- Attending Physician, Endocrinology/Diabetes, Oishei Children's Hospital (2004-present)
- Associate Professor, Pediatrics, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences (2013–2022)
- Associate Division Chief, Endocrinology/Diabetes, UBMD Pediatrics (2014–2017)
- Assistant Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2012–2013)
- Research Assistant Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2010–2012)
- Assistant Professor, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2005–2010)
Awards and Honors:
- Buffalo Spree Magazine: Top Doctors in Western New York (2016-2023) (2023)
- Castle Connolly Medical Ltd: America‘s Top Doctors (2016-2023) (2023)
- Castle Connolly Medical Ltd: Exceptional Women in Medicine (2019)
- Pediatric Endocrine Society: Leadership Advantage “Award of Accomplishment and Exemplary Completion” (2019)
- Gold Humanism Honor Society: Richard Sarkin/Emeritus Faculty Chapter Faculty Inductee (2019)
- American Diabetes Association: Mission Recognition "Exemplary Service Award" (2012)
- Society for Pediatric Research: Awarded Membership (2012)
- 85th Annual Endocrine Society Conference: Genentech Travel Grant (2003)
- Alpha Omega Alpha Honor Medical Society (1998)
- Edward A. Carr Pharmacology Award (1992)
- Phi Beta Kappa Honor Society (1990)
- Sigma Xi Honor Society (1989)
- PEW Fellowship Recipient (1989)
- Elks' National Scholarship (1986)
- Bausch and Lomb: Science Award (1986)
- Endocrine Fellows Foundation Award (2002-2003)
- Manhattan College: Presidential Scholarship (1986-1990)
- Castle Connolly: Exceptional Women in Medicine (2019-2022)
Research Expertise:
- Congenital Adrenal Hyperplasia
- Growth hormone deficiency
- Late Endocrine effects of childhood cancer
- Type 1 diabetes
- Type 2 diabetes
- Weight management and obesity
Grants and Sponsored Research:
- January 2021–December 2021
School Attendance for Children with Type 1 Diabetes during the COVID Pandemic
Wildermuth Memorial Foundation
Role: Co-Principal Investigator
$6,700 - August 2015–July 2020
Delay Discounting as a Target for Self-Regulation in Prediabetes
National Institute of Diabetes and Digestive and Kidney Diseases
Role: Co-Investigator
$2,417,153 - May 2015–February 2020
Targeting Polyamines Using DFMO in Persons with T1D
Indiana University Board of Trustees
Role: Co-Principal Investigator
$93,769 - January 2017–January 2020
A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents with Type 2 Diabetes and Clinical Study
AstraZeneca
Role: Principal Investigator - December 2016–December 2018
A 6-Month, Multi-Center, Randomized, Open-Label, 2-Arm, Parallel Group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus Injected Once Daily in Children and Adolescents with Type 1 Diabetes
Sanofi
Role: Principal Investigator - November 2016–November 2018
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects with Obesity. A 56-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Multi-National Trial
NovoNordisk
Role: Principal Investigator - September 2016–September 2018
A 24-Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28-Week Long-Term Safety Extension Phase Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Subjects Age 10-24 Years
AstraZeneca
Role: Principal Investigator - May 2016–May 2018
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
Novo Nordisk
Role: Principal Investigator - February 2015–January 2018
Efficacy and Safety of Liraglutide in Combination with Metformin vs. Metformin on Glycaemic Control in Children and Adolescents with Type 2 Diabetes - A 26-Week Double-Blind, Randomized, Parallel Group, Placebo-Controlled Multi-Center Trial
Novo Nordisk
Role: Principal Investigator
$9,601 - February 2016–December 2017
Accu-Chek Connect at School (CATS) Pediatric Study
Roche
Role: Principal Investigator
$5,001 - February 2016–March 2017
Development of a Multisensory System for Continuous Monitoring of Blood Glucose Level
University at Buffalo Innovative Micro-Programs Accelerating Collaboration in Themes (IMPACT)
Role: Co-Investigator
$35,000 - April 2015–March 2017
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of LX4211 in Young Adult Patients with Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C
Lexicon Pharmaceuticals
Role: Co-Investigator
$318,867 - March 2015–March 2017
Periodontal Disease, the Oral Microbiome, and Type 2 Diabetes in Children
Colgate-Palmolive Company
Role: Co-Principal Investigator - July 2014–June 2016
Environmental Circadian Disruptors Increase Diabetes and Metabolic Disorders Risk
National Institutes of Health
Role: Consultant
$437,342 - September 2014–August 2015
A 26-Week Open-Label, Randomized, 2-Armed, Parallel Group, Multi-Centre Trial Investigating Efficacy and Safety of Insulin Determir vs. Insulin Neutral Protamine Hagedorn in Combination with Metformin and Diet/Exercise on Glycaemic Control
Novo Nordisk
Role: Principal Investigator
$18,395 - December 2012–November 2014
Anti-Diabetic Effects of Liraglutide in Adolescents and Young Subjects with Type 1 Diabetes
American Diabetes Association
Role: Co-Principal Investigator
$600,000 - August 2022
A 2-stage (open-label run-in followed by randomized withdrawal), double-blind, placebo-controlled, Phase 2 study of setmelanotide in patients with specific gene defects in the melanocortin-4 receptor pathway
Rhythm Pharmaceuticals, Inc.
Role: Principal Investigator - May 2022
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of 400 mg twice a day oral Ladarixin in Patients with Recent Onset Type 1 Diabetes and a Low Residual ß-cell Function at Baseline (LDX0319, Study name: Gladiator)
Dompe Farmaceutici
Role: Principal Investigator - September 2019
Effect and safety of semaglutide 2.4 mg once weekly on weight management in adolescents with overweight or obesity
Novo Nordisk
Role: Principal Investigator - July 2019
Beyond Compartment Models: Using Big-Data to Enhance Models for Controller Development for the Artificial Pancreas
Juvenile Diabetes Research Foundation
Role: Co-Investigator - April 2019
Avoiding Recidivism in Bariatric Surgery
University at Buffalo: Blue Sky Fund
Role: Co-Investigator
$25,000 - December 2018
Assessment of Adrenal Function After ACTH Treatment in Children with Infantile Spasms
Wildermuth Foundation
Role: Co-Principal Investigator
$25,000 - April 2017
Role of Contingency Management in the Treatment of Youth and Their Parents in a Pediatric Tertiary Care Weight Management Program
University at Buffalo Clinical and Translational Science Institute
Role: Co-Investigator
$42,000 - December 2016
Comparison of the safety and efficacy of HOE901-U300 with Lantus in children and adolescent with Type 1 diabetes mellitus
Sanofi
Role: Principal Investigator - August 2016
A trial to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of liraglutide in obese children aged 7-11 years
Novo Nordisk
Role: Principal Investigator - September 2011
Effect of Liraglutide on Glycemic Control, Glucagon Secretion and Inflammatory Markers in Adolescents with Type 1 Diabetes Mellitus
Medtronic Corporation
Role: Principal Investigator
$6,000 - August 2010
Type 1 Diabetes Exchange
Jaeb Center for Health Research
Role: Co-Investigator
$422,037 - May 2006
Type 1 Diabetes TrialNet
National Institute of Diabetes and Digestive and Kidney Diseases
Role: Co-Investigator
$311,019 - Effect and safety of liraglutide 3.0 mg on weight management in children with obesity aged 6 to <12 years; 56-week, double-blind, randomised, placebo-controlled trial
NovoNordisk
Role: Principal Investigator
Journal Articles:
- Thanos PK, Hanna C, Mihalkovic A, Hoffman AB, Posner AR, Busch J, Smith C, Badgaiyan RD, Blum K, Baron D, Mastrandrea LD, Quattrin T. (2023) The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research. Journal of personalized medicine (Jul), 13(7). doi:10.3390/jpm13071164
- Quattrin T, Mastrandrea LD, Walker LSK. (2023) Type 1 diabetes. Lancet (London, England) (Jun), 401(10394): 2149-2162.
- Majumdar I, Talal AH, Harmon CM, Tabaczynsk E, Cercone K, Wrotniak BH, Mastrandrea LD, Quattrin T. (2023) Role of Dual-Contingency Management in Family-Based Obesity Therapy and the Effects of Weight Loss on Liver Transient Elastography Parameters in Youth: A Pilot Study. Cureus (Mar), 15(3): e36629. doi:10.7759/cureus.36629
- Weghuber D, Barrett T, Barrientos-Pérez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Sørrig R, Arslanian S, . (2022) Once-Weekly Semaglutide in Adolescents with Obesity. The New England journal of medicine (Dec), 387(24): 2245-2257.
- Mastrandrea LD, Quattrin T. (2022) Preventing type 1 diabetes development and preserving beta-cell function. Current opinion in endocrinology, diabetes, and obesity (Aug), 29(4): 386-391.
- Wolf RM, Cheng P, Gal RL, Beaulieu LC, Kollman C, Isganaitis E, Magge S, Mastrandrea LD, Klingensmith GJ, Tamborlane W, Van Name M, . (2022) Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study. Pediatric diabetes (Jun), 23(4): 439-446.
- Epstein LH, Paluch RA, Biondolillo MJ, Stein JS, Quattrin T, Mastrandrea LD, Gatchalian K, Greenawald MH, Bickel WK. (2022) Effects of 6-month episodic future thinking training on delay discounting, weight loss and HbA1c changes in individuals with prediabetes. Journal of behavioral medicine (Apr), 45(2): 227-239. doi:10.1007/s10865-021-00278-y
- Zaidi SMA, Chandola V, Ibrahim M, Romanski B, Mastrandrea LD, Singh T. (2021) Multi-step ahead predictive model for blood glucose concentrations of type-1 diabetic patients. Scientific reports (Dec), 11(1): 24332. doi:10.1038/s41598-021-03341-5
- Carlsson Petri KC, Hale PM, Hesse D, Rathor N, Mastrandrea LD. (2021) Liraglutide pharmacokinetics and exposure-response in adolescents with obesity. Pediatric obesity (Oct), 16(10): e12799.
- Bhinder J, Bethin K, Kukar M, Mastrandrea LD, Rothstein DH. (2021) Association of same-day discharge with hospital readmission after pediatric thyroidectomy. Pediatric surgery international (Sep), 37(9): 1259-1264.
- Htun ZT, Schulz EV, Desai RK, Marasch JL, McPherson CC, Mastrandrea LD, Jobe AH, Ryan RM. (2021) Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia. Journal of perinatology : official journal of the California Perinatal Association (Aug), 41(8): 1783-1796. doi:10.1038/s41372-021-01083-w
- Shelat T, Mastrandrea LD, Majumdar I, Quattrin T. (2021) Perceptions of Diabetes Self-Efficacy and Glycemic Control in Youth With Type 1 Diabetes. Diabetes spectrum : a publication of the American Diabetes Association (Aug), 34(3): 313-320. doi:10.2337/ds20-0035
- Mamilly L, Mastrandrea LD, Vasquez CM, Klamer B, Kallash M, Aldughiem A. (2021) Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes. Front Endocrinol (Apr)
- Mamilly L, Mastrandrea LD, Mosquera Vasquez C, Klamer B, Kallash M, Aldughiem A. (2021) Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes. Frontiers in endocrinology (Jan), 12: 669954. doi:10.3389/fendo.2021.669954
- Stein JS, Craft WH, Paluch RA, Gatchalian KM, Greenawald MH, Quattrin T, Mastrandrea LD, Epstein LH, Bickel WK. (2020) Bleak present, bright future: II. Combined effects of episodic future thinking and scarcity on delay discounting in adults at risk for type 2 diabetes. J Behav Med (Sep).
- Bickel WK, Stein JS, Paluch RA, Mellis AM, Athamneh LN, Quattrin T, Greenawald MH, Bree KA, Gatchalian KM, Mastrandrea LD, Epstein LH. (2020) Does Episodic Future Thinking Repair Immediacy Bias at Home and in the Laboratory in Patients With Prediabetes?. Psychosom Med (Sep), 82(7): 699-707.
- Epstein LH, Paluch RA, Stein JS, Quattrin T, Mastrandrea LD, Bree KA, Sze YY, Greenawald MH, Biondolillo MJ, Bickel WK. (2020) Delay Discounting, Glycemic Regulation and Health Behaviors in Adults With Prediabetes. Behav Med (Apr)
- Casu A, Kanapka LG, Foster NC, Hirsch IB, Laffel LM, Shah VN, DeSalvo DJ, Lyons SK, Vendrame F, Aleppo G, Mastrandrea LD, Pratley RE, Rickels MR, Peters AL, T1D Exchange Clinic Network. (2020) Characteristics of Adult- Compared to Childhood-Onset Type 1 Diabetes. Diabet Med (Apr)
- Kelly AS, Auerbach P, Barrientos‑Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S, NN8022-4180 Trial Investigators. (2020) A Randomized, Controlled Trial of Liraglutide for Adolescents With Obesity. N Engl J Med (Mar)
- Epstein LH, Paluch RA, Stein JS, Mellis AM, Quattrin T, Mastrandrea LD, Bree KA, Greenawald MH, Bickel WK. (2019) Role of Delay Discounting in Predicting Change in HBA1c for Individuals With Prediabetes. J Behav Med (Oct), 42(5)
- Chapman AK, Farmer ZJ, Mastrandrea LD, Matlock KA. (2019) Neonatal Thyroid Function and Disorders. Clin Obstet Gynecol (Jun), 62(2)
- Mastrandrea LD, Witten L, Carlsson Petri KC, Hale PM, Hedman HK, Riesenberg RA. (2019) Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Pediatr Obes (May), 14(5)
- Thirunagari R, Marrone A, Elsinghorst H, Mastrandrea LD. (2018) Hematuria as an adverse outcome following provocative growth hormone stimulation testing in children. J Pediatr Endocrinol Metab (Apr), 31(5)
- Janem WF, Scannapieco FA, Sabharwal A, Tsompana M, Berman HA, Haase EM, Miecznikowski JC, Mastrandrea LD. (2017) Correction: Salivary inflammatory markers and microbiome in normoglycemic lean and obese children compared to obese children with type 2 diabetes. PLoS One (Aug), 12(8)
- Jiao N, Baker SS, Chapa Rodriguez A, Liu W, Nugent CA, Tsompana M, Mastrandrea LD, Buck M, Baker RD, Genco RJ, Zhu R, Zhu L. (2017) Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut (Aug)
- Jiao N, Baker SS, Chapa Rodriguez A, Liu W, Nugent CA, Tsompana M, Mastrandrea LD, Buck M, Baker RD, Genco RJ, Zhu R, Zhu L. (2017) Suppressed Hepatic Bile Acid Signaling Despite Elevated Production of Primary and Secondary Bile Acids in NAFLD. Gastroenterology (Apr), 152(5 S1)
- Wong D, Boyle C, DiMeglio LA, Mastrandrea LD, Abel KL, Cengiz E, Cemeroglu PA, Aleppo G, Largay JF, Foster NC, Beck RW, Adi S, T1D Exchange Clinic Network. (2017) Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry. J Diabetes Sci Technol (Mar), 11(22)
- Janem WF, Scannapieco FA, Sabharwal A, Tsompana M, Berman HA, Haase EM, Miecznikowski JC, Mastrandrea LD. (2017) Salivary inflammatory markers and microbiome in normoglycemic lean and obese children compared to obese children with type 2 diabetes. PloS one (Jan), 12(3): e0172647. doi:10.1371/journal.pone.0172647
- Janem W, Mastrandrea LD. (2016) Testicular failure following severe diabetic ketoacidosis complicated by hypotensive shock. Clin Case Rep (Mar), 4(4)
- Mastrandrea LD. (2015) An Overview of Organ-Specific Autoimmune Diseases Including Immunotherapy. Immunol Invest (Nov), 44(8)
- Danilovich N, Mastrandrea LD, Cataldi L, Quattrin T. (2014) Methylphenidate decreases fat and carbohydrate intake in obese teenagers. Obesity (Silver Spring) (Mar), 22(3)
- Desai S, Baker SS, Liu W, Moya DA, Browne RW, Mastrandrea LD, Baker RD, Zhu L. (2014) Paraoxonase-1 and oxidative stress in paediatric non-alcoholic steatohepatitis. Liver Int (Jan), 34(1)
- Mastrandrea LD. (2013) Role of sphingosine kinases and sphingosine 1-phosphate in mediating adipogenesis. J Diabetes Mellitus (May), 3(2)
- Majumdar I, Mastrandrea LD. (2012) Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine (Jun), 41(3)
- Patel RA, Baker SS, Liu W, Desai S, Alkhouri RH, Kozielski R, Mastrandrea LD, Sarfraz S, Cai W, Vlassara H, Patel MS, Baker RD, Zhu L. (2012) Effect of Dietary Advanced Glycation End Products on Mouse Liver. PLoS ONE (Apr), 7(4)
- Mastrandrea LD, Albini CH, Wynn RJ, Greenfield SP, Robinson LK, Mazur T. (2012) Disorders of sex development: management of gender assignment in a preterm infant with intrauterine growth restriction. Case Rep Med (Mar), 2012
- Hasan NM, Longacre MJ, Stoker S, Kendrick MA, Druckenbrod NR, Laychock SG, Mastrandrea LD, MacDonald MJ. (2012) Sphingosine kinase 1 knockdown reduces insulin synthesis and secretion in a rat insulinoma cell line. Arch Biochem Biophys (Feb), 518(1)
- Patel R, Baker SS, Liu W, Desai S, Alkhouri RH, Kozielski R, Mastrandrea LD, Sarfraz A, Cai W, Vlassara H, Patel MS, Baker RD, Zhu L. (2012) Effect of dietary advanced glycation end products on mouse liver. PLoS ONE (Jan), 7(4)
- Mastrandrea LD. (2012) Managing diabetes with inhaled insulin. Reviews in Health Care (Jan), 3(1)
- Majumdar I, Mastrandrea LD. (2010) Lingual thyroid as a cause of primary hypothyroidism: congenital hypothyroidism in the neonatal period and beyond. Clin Pediatr (Phila) (Sep), 49(9)
- Mastrandrea LD. (2010) A breath of life for inhaled insulin: severe subcutaneous insulin resistance as an indication?. Pediatr Diabetes (Sep), 11(6)
- Mastrandrea LD, Sessanna SM, Del Toro A, Laychock SG. (2010) ATP-independent glucose stimulation of sphingosine kinase in rat pancreatic islets. J Lipid Res (Aug), 51(8)
- Daniel M, Mastrandrea LD, Salis R, Erbe RW, Quattrin T. (2010) Does the dopamine transporter protein allele predict growth hormone testing results or response to growth hormone therapy?. Endocrine (Apr), 37(2)
- Mastrandrea LD. (2010) Inhaled insulin: overview of a novel route of insulin administration. Vasc Health Risk Manag (Mar), 6
- Mastrandrea LD, Yu J, Behrens T, Buchlis JG, Albini CH, Fourtner SH, Quattrin T. (2009) Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care (Jul), 32(7)
- Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T. (2008) Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care (Sep), 31(9)
- Laychock SG, Sessanna SM, Mastrandrea LD. (2007) Sphingosine Kinase Expression and Activity in Rat Pancreatic Islets. Diabetes (Jun), 56(1)
- Mastrandrea LD, Albini CH. (2006) Bisphosphonate treatment of tumor-induced hypercalcemia in a toddler: case report and review of related literature. Endocr Pract (Nov), 12(6)
- Mastrandrea LD, Quattrin T. (2006) Clinical evaluation of inhaled insulin. Adv Drug Deliv Rev (Oct), 58(9-10)
- Laychock SG, Sessanna SM, Lin MH, Mastrandrea LD. (2006) Sphingosine 1-phosphate affects cytokine-induced apoptosis in rat pancreatic islet beta-cells. Endocrinology (Oct), 147(10)
- Mastrandrea LD, Martin DJ, Springate JE. (2005) Clinical and biochemical similarities between reflux/obstructive uropathy and salt-wasting congenital adrenal hyperplasia. Clin Pediatr (Phila) (Nov), 44(9)
- Mastrandrea LD, Sessanna SM, Laychock SG. (2005) Sphingosine kinase activity and sphingosine-1 phosphate production in rat pancreatic islets and INS-1 cells: response to cytokines. Diabetes (May), 54(5)
- Mastrandrea LD, You J, Niles EG, Pickart CM. (1999) E2/E3-mediated assembly of lysine 29-linked polyubiquitin chains. J Biol Chem (Sep), 274(38)
- Mastrandrea LD, Kasparek EM, Niles EG, Pickart CM. (1998) Core domain mutation (S86Y) selectively inactivates polyubiquitin chain synthesis catalyzed by E2-25K. Biochemistry (Jul), 37(27)
- Wefes I, Mastrandrea LD, Haldeman M, Koury ST, Tamburlin J, Pickart CM, Finley D. (1995) Induction of ubiquitin-conjugating enzymes during terminal erythroid differentiation. Proc Natl Acad Sci U S A (May), 92(11)
- Shenkin PS, Erman B, Mastrandrea LD. (1991) Information-theoretical entropy as a measure of sequence variability. Proteins (Jan), 11(4)
Books and Book Chapters:
- Mojica AP, Mastrandrea LD. (2015) In: "Pubertal Delay".
- Mastrandrea LD. (2012) In: "Organ and Tissue Specific Autoimmunity".
- Mastrandrea LD. (2010) In: "Autoimmune Disorders Associated with Type 1 Diabetes Mellitus: Diagnosis and Implications for Diabetes Control".
Abstracts:
- Mastrandrea LD, Laychock SG, Sessanna SM. (2006) Sphingosine Kinase in Pancreatic Islets is Activated by Glucose and Glucose Analogues. Diabetes, (Jun)
- Mastrandrea LD, Laychock SG. (2005) Sphingosine Kinase 2 is the Predominant Enzyme in Rat Pancreatic Islets and INS-1 Cells and is Activated by Cytokines. FASEB J, (Apr)
Professional Memberships:
- American Academy of Pediatrics, Section on Advanced Therapeutics and Technology; Member (2022–2023)
- American Academy of Pediatrics Section on Endocrinology; Member (2018–2023)
- American Diabetes Association (2017–2022)
- Society for Pediatric Research (2012–present)
- The Endocrine Society (2008–present)
- American Academy of Pediatrics: Young Physicians Society (2007–2013)
- Medical Society of the State of New York (2005–2008)
- American Academy of Pediatrics: Fellow (FAAP) (2004–present)
- American Association of Clinical Endocrinologists (2004–2009)
- Lawson Wilkins Society of Pediatric Endocrinology/Pediatric Endocrine Society (2001–present)
- American Medical Association (2000–2004)
Presentations:
- "Is that a thyroid issue? Story in three acts plus a PSA." Pediatric Grand Rounds, Oishei Children's Hospital of Buffalo (2022)
- "Progress in Diabetes Management" Pediatric Grand Rounds; University at Buffalo (2020)
- "Youth with Type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: a Pediatric Diabetes Consortium Study" Annual Meeting; American Diabetes Association (2020)
- "Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial" ENDO 2020; Endocrine Society (2020)
- "Breakthrough diabetes insulin drug developed with help from Buffalo" Media Interview; Buffalo News (2020)
- "Buffalo clinical trial contributed to FDA approval for fast-acting insulin for children" Media Interview; Niagara Frontier Publications/WGRZ Channel 2 News/WEHC News10NBC (2020)
- "HbA1c Trajectories from Time of Diagnosis in Youth with T1D" Annual Meeting; American Diabetes Association (2019)
- "Pediatric Metabolic Bone Disease" Pediatric Grand Rounds; University at Buffalo (2019)
- "Type 1 Diabetes: Research Update" Western New York Chapter Annual Meeting; Juvenile Diabetes Research Foundation (2019)
- "Monogenic Diabetes Type 5 (MODY-5) in a Pediatric Patient: A Case Report" Annual Meeting; Pediatric Academic Societies; Endocrinology: Genetics/Syndromes 3 (2019)
- "Type 1 Diabetes: Lessons Learned from TrialNet and How Protect the Pancreatic Beta-cell" Support Group Meeting; D-Link (2019)
- "Urinary Markers of Diabetic Nephropathy: Relationship to Blood Pressure and Glycemic Variability in Pediatric Type 1 Diabetes" Annual Meeting; Pediatric Academic Societies; Type 1 Diabetes 3 (2019)
- "Changes in Transient Elastography in Obese Youth With Intensive Weight Management" Obesity Week; The Obesity Society (2018)
- "Management and Recognition of Pediatric Thyroid Disease: A Story in Three Acts" Annual Meeting; Western New York National Association of Pediatric Nurse Practitioners (2018)
- "Role of Dual Contingency Management for Weight Management in Disadvantaged Families: A Pilot Study" Obesity Week; The Obesity Society (2018)
- "Now or Later: Do Adolescents with Type 1 Diabetes Discount the Future?" Pediatric Grand Rounds; Riley Hospital for Children (2018)
- "Characteristics of Adult vs. Childhood Onset Type 1 Diabetes in the T1D Exchange Registry" 78th Scientific Sessions; American Diabetes Association (2018)
- "Presentation and Clinical Characteristics of Patients with Maturity Onset Diabetes of the Young (MODY) at Women and Children's Hospital of Buffalo" 78th Scientific Sessions; American Diabetes Association (2018)
- "A Noninvasive Glucose Estimation Based on Near Infrared Spectroscopy and Pulse-Echo Ultrasound" ICBEM & RGC 2018; RWTH Aachen University (2018)
- "Blood Glucose Levels During Pregnancy on Women's Motivation to Eat" Ingestive Behavior Research Day; University at Buffalo (2018)
- "Research in Type 1 Diabetes: Where We Were, Where We are Going" Support Group Meeting; D-Link (2018)
- "Glycemic Control and Executive Function in Adolescents with Type 1 Diabetes" 10th International Meeting of Pediatric Endocrinology; Pediatric Endocrine Society (2017)
- "Microscopic Hematuria Following Ambulatory Provocative Growth Hormone Stimulation Testing in Children" 10th International Meeting of Pediatric Endocrinology; Pediatric Endocrine Society (2017)
- "High Diabetes Self-Efficacy and Quality of Life Scores are Not Sufficient to Achieve Optimal Glycemic Control in Youth with Type 1 Diabetes" 77th Scientific Sessions; American Diabetes Association (2017)
- "The Road to Type 1 Diabetes Cure: An Update" Western New York Chapter Meeting; Juvenile Diabetes Research Foundation (2017)
- "Lessons Learned from TrialNet and Other Progress in Type 1 Diabetes" Support Group Meeting; D-Link (2017)
- "Optimal Meal Time After Blousing for Type 1 Diabetes Patients Under Meal Uncertainties" American Control Conference; American Automatic Control Council (2017)
- "Suppressed Hepatic Bile Acid Signaling Despite Elevated Production of Primary and Secondary Bile Acids in NAFLD" Digestive Disease Week; American Gastroenterological Association (2017)
- "Recruitment Strategies and Success Stories: The Women and Children‘s Hospital of Buffalo Experience" Investigator Meeting; Sanofi (2017)
- "Iatrogenic Adrenal Insufficiency: Recognition and Management" Division of Allergy/Immunology Lecture Series; University at Buffalo (2017)
- "Lessons Learned from TrialNet: Risk Factors for Type 1 Diabetes" Pediatric Grand Rounds; University at Buffalo (2017)
- "Primary Hyperaldosteronism" Meet the Professor Series: Pediatric Endocrinology Fellowship Lecture; Western New York Association of School Nurses (2017)
- "Diabetes in the Pediatric Population: Diagnosis, Prediction and the Team" Western New York School Nurse In-Service Event; Juvenile Diabetes Research Foundation (2016)
- "Research Update" Annual Meeting; Juvenile Diabetes Research Foundation Western New York Chapter (2016)
- "Road to Type 1 Diabetes Cure" Western New York Chapter Meeting; Juvenile Diabetes Research Foundation (2016)
- "Transcriptional Regulation of Paraoxonase 1 in Pediatric NAFLD Livers" Digestive Disease Week; American Gastroenterological Association (2016)
- "Globe Subluxation in a Pediatric Patient Presenting with Minimal Signs of Thyroid Orbitopathy" ENDO 2016; Endocrine Society (2016)
- "Hematuria is Rare Following Provocative Growth Hormone Stimulation Testing in Children" ENDO 2016; Endocrine Society (2016)
- "Pediatric Diabetes - Updates and Current Trends" Invited Presentation; Western New York National Association of Pediatric Nurse Practitioners (2015)
- "Diabetes in the Pediatric Population: Diagnosis and Technology Updates" Western New York School Nurse In-Service Event; Juvenile Diabetes Research Foundation (2015)
- "Elevated Irisin Expression in NASH Livers" Scholarly Exchange Day; University at Buffalo (2015)
- "Correlation of Irisin Expression with Inflammatory Markers in Liver" Annual Meeting; Experimental Biology (2015)
- "Elevated Irisin Expression in NASH Livers" Annual Meeting; Experimental Biology (2015)
- "Environmental Circadian Modulators Target Melatonin Receptors in Pancreatic β-Cells" Annual Meeting; Experimental Biology; ASPET Scientific Section (2015)
- "The Road to Type 1 Diabetes Cure: Type 1 Until Type None, Research Advances" Support Group Meeting; D-Link (2015)
- "Ensuring Quality Care in Pediatric Diabetes – Current and Future Developments" Pediatric Grand Rounds; University at Buffalo (2015)
- "The Road to Type 1 Diabetes Cure" Northwest Pennsylvania Research Meeting; Juvenile Diabetes Research Foundation (2015)
- "The Raising of America" Local Forum (2014)
- "Elevated Irisin Expression in NASH Livers" Annual Meeting; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (2014)
- "Pediatric Diabetes: Diagnosis, Treatment, Progress" Western New York School Nurses In-Service Event; Juvenile Diabetes Research Foundation (2014)
- "Osteopenia and Osteoporosis in Adult Females with Type 1 Diabetes: Results from the T1D Exchange Registry" Annual Meeting; American Society for Bone and Mineral Research (2014)
- "Comparison of Oral Disease in Children of Normal Weight, Obesity, or Type 2 Diabetes" ICE/ENDO 2014; Endocrine Society (2014)
- "Effect of Vitamin D Deficiency/Insufficiency Treatment on Insulin Resistance in Obese and Overweight Children" ICE/ENDO 2014; Endocrine Society (2014)
- "Research Update" Annual Meeting; Juvenile Diabetes Research Foundation: Western New York Chapter (2014)
- "Effect of Sphingosine 1-Phosphate on Lipolytic Machinery in 2T2-L1 Adipocytes" Joint Meeting; Pediatric Academic Societies/Asian Society for Pediatric Research (2014)
- "Creating a World Without Type 1 Diabetes: Type 1 Until Type None" Support Group Meeting; D-Link (2014)
- "Psychologic Aspects of Diabetes in the Pediatric Population" Invited Presentation; Psychological Association of Western New York (2014)
- "Pediatric Diabetes: Diagnosis, Treatment, Trends, Progress" Western New York School Nurses In-Service Event; Juvenile Diabetes Research Foundation (2013)
- "Current Development in Diabetes Research: Mission for a Cure" Support Group Meeting; D-Link (2013)
- "Management of the Pediatric Patient with Diabetes: Diagnosis, Trends, Treatment, Progress" Invited Presentation; Western New York American Association of Diabetes Educators (2013)
- "Row for Juvenile Diabetes Research Foundation and Type 1 Diabetes" Media Interview; WJYE-FM; Spotlight on Health (2012)
- "Chronic Sphingosine 1-Phosphate Treatment of Adipocytes Downregulates Lipolytic Enzymes" 72nd Scientific Sessions; American Diabetes Association (2012)
- "Growth Disorders in the Pediatric Population" Grand Rounds; Women‘s Christian Association Hospital (2012)
- "Horizons in Type 1 Diabetes Research: Update on JDRF at Work in 2012" Annual Meeting; Juvenile Diabetes Research Foundation; Western New York Chapter (2012)
- "Impact of Paraoxonase 1 (Pon1) in Pediatric Non-Alcoholic Steatohepatitis (NASH) Livers" Research Day; University at Buffalo (2012)
- "Effect of Dietary Advanced Glycation End Products on Mouse Liver" Annual Meeting; Federation of American Societies for Experimental Biology (2012)
- "Impact of Paraoxonase 1 (Pon1) in Pediatric Non-Alcoholic Steatohepatitis (NASH) Livers" Annual Meeting; Pediatric Academic Societies (2012)
- "Insulin Resistance in the Obese Pediatric Population: Contributing Factors and Treatment Dilemmas" Pediatric Grand Rounds; Medical University of South Carolina (2012)
- "The Insulin-resistant Adipocyte: Role of Sphingosine 1-Phosphate" Division of Pediatric Endocrinology Meeting; Medical University of South Carolina (2012)
- "Diabetes Research: Beyond Fingersticks, Shots and Insulin Pump Therapy" Support Group Meeting; D-Link (2011)
- "Diabetes in the School Setting: Daily and Emergency Management" Diabetes Update for School Nurses, Western New York; JDRF/Johnson and Johnson/Women and Children‘s Hospital of Buffalo (2011)
- "Serum Ceramide Levels are Associated with Insulin Resistance in Obese Adolescents" Annual Meeting; Pediatric Academic Societies/Society for Pediatric Research (2011)
- "Adipocytokines and Insulin Resistance in the Obese Pediatric Population" Pediatric Grand Rounds; University at Buffalo (2011)
- "Association of Serum Sphingolipids and Serum Adipocytokines with Insulin Resistance in Adolescents at Risk for Metabolic Syndrome" Annual Conference; Eastern Society for Pediatric Research (2011)
- "Adipocytokines and Insulin Resistance in the Obese Pediatric Population" Pediatric Grand Rounds; Louisiana State University Health Sciences Center and Children‘s Hospital (2010)
- "Sphingolipids and Insulin Resistance" Department of Pediatric Endocrinology Research Group Meeting; Louisiana State University Health Sciences Center (2010)
- "Diabetes in the School Setting: Daily and Emergency Management" Diabetes Update for School Nurses, Western New York; JDRF/Johnson and Johnson/Women and Children‘s Hospital of Buffalo (2010)
- "Sphingosine Kinase and Sphingosine 1-Phosphate in Adipocyte Differentiation and Development of Insulin Resistance" Research Conference; Arkansas Children's Hospital Research Institute (2010)
- "Serum Sphingolipids and Serum Inflammatory Mediators in Adolescents at Risk for Metabolic Syndrome" ENDO 2010; Endocrine Society (2010)
- "Sphingosine Kinase and Sphingosine 1-Phosphate: Role in Adipocyte Differentiation and Development of Insulin Resistance" Joslin Diabetes Center Meeting; SUNY Upstate Medical University; Department of Medicine (2010)
- "Standards of Medical Care: The Diabetes Clinic Experience" Pediatric Grand Rounds; University at Buffalo (2010)
- "Sphingosine 1-Phosphate Activation of AKT Kinase in Adipocytes" Annual Meeting; Lawson Wilkins Pediatric Endocrine Society (2009)
- "Premature Neonate with Disorder of Sexual Development and Absent Adrenal Glands" ENDO 2009; Endocrine Society (2009)
- "Obesity Epidemic: Understanding Your Role as a Student and Future Physician" Americal Medical Association - Medical Students Society; University at Buffalo (2009)
- "Diabetes and Disorders of Low Bone Mass" Epidemiology of Type 2 Diabetes and Related Disorders; University at Buffalo; Social and Preventive Medicine (2009)
- "Management of Diabetic Ketoacidosis in the Pediatric Population" Pediatric Intensive Care Fellowship Lecture Series; Women and Children's Hospital of Buffalo (2009)
- "Growth Disorders in the Pediatric Population" Pediatric Grand Rounds; Mercy Hospital of Buffalo (2009)
- "Phospholipids in Insulin Resistance: Sphingosine Kinase Expression and Activity" Pulmonary Biology Research Seminar Series; University at Buffalo (2009)
- "Obesity and Adipocytokines: The Adipocyte as a Proinflammatory Cell" Medical Club Meeting; Roswell Park Cancer Institute (2008)
- "Sphingosine Kinase Expression and Activity in Insulin-resistant Adipocytes" Seminar Series; University at Buffalo; Department of Exercise and Nutrition Sciences (2008)
- "How to be Proactive in Diabetes Management" Diabetes Day; Buffalo Zoo (2008)
- "Sphingosine Kinase Expression and Activity in Insulin-resistant Adipocytes" ENDO 2008; Endocrine Society (2008)
- "Evaluation of Growth Disorders" Bi-Monthly Meeting; Buffalo Pediatric Society (2008)
- "Turner Syndrome: A Review" Eli Lilly Lecture Series; Women and Children‘s Hospital of Buffalo; Division of Pediatric Endocrinology (2008)
- "Growth Disorders: Management Using a Team's Approach" Annual Family Meeting; Children's Growth Foundation (2008)
- "Pediatric Growth Disorders" Eli Lilly Lecture Series; Western New York Nurse Practitioners Association (2008)
- "The Adipocyte as an Endocrine Proinflammatory Cell" Department of Medicine City-Wide Grand Rounds; University of Buffalo (2008)
- "Management of Diabetic Ketoacidosis in the Pediatric Population" Pediatric Intensive Care Fellowship Lecture Series; Women and Children's Hospital of Buffalo (2007)
- "Polycystic Ovary Syndrome: Diagnosis and Management" Dermatology Grand Rounds; University at Buffalo (2007)
- "Pediatric Growth Disorders" Eli Lilly Lecture Series; Jamestown Pediatrics (2007)
- "An Unusual Case of Hypoglycemia" ENDO 2007; Endocrine Society (2007)
- "Case Studies in Pediatric Growth Disorders" Eli Lilly Lecture Series; Women and Children‘s Hospital of Buffalo; Division of Pediatric Endocrinology (2007)
- "Growth Disorders in the Pediatric Population: Recognition and Management" Endocrine Fellows Lecture; University at Buffalo (2007)
- "Thyroid Disorders in the Neonate" Division of Neonatology Lecture Series; Women and Children's Hospital of Buffalo (2007)
- "Type 1 Diabetes: Updates in Research and Clinical Trials" Pediatric Grand Rounds; University at Buffalo (2006)
- "Clinical Trials and Research Update in Type 1 Diabetes" Group Meeting; Erie County Family Support Group (2006)
- "Horizons in Type 1 Diabetes Research: JDRF at Work" Annual Meeting; Juvenile Diabetes Research Foundation; Western New York Chapter (2006)
- "Research Updates in Type 1 Diabetes" Group Meeting; Niagara Falls Family Support Group (2006)
- "Neonatal's Grave Disease - Diagnosis and Management" Perinatology/Neonatology Joint Conference; Women and Children's Hospital of Buffalo (2005)
- "Sphingosine Kinase 2 is the Predominant Enzyme in Rat Pancreatic Islets and INS-1 Cells and is Activated by Cytokines" Annual Meeting; Federation of American Societies of Experimental Biology (2005)
- "Fertility and Turner's Syndrome" Annual Family Meeting; Children's Growth Foundation (2005)
- "Regulation of Sphingosine 1-Phosphate Levels in Pancreatic Beta-cells" Fellows Conference; Juvenile Diabetes Research Foundation (2005)
- "Management of Hyperthyroidism: A Review - 14 Year Old Female Presenting with Thyroid Storm" Pediatric Resident Case Conference; Women and Children‘s Hospital of Buffalo (2005)
- "Characterization of Sphingosine 1-Phosphate Phosphohydrolase Activity in INS-1 Cells" Annual Meeting; Federation of American Societies for Experimental Biology (2004)
- "Sphingosine 1-Phosphate Biosynthesis in Beta-cells" Invited Presentation; Boston-Ithaca Islet Club (2003)
- "Sphingosine Kinase and Sphingosine 1-Phosphate: Putative Mediators of Cytokine Responses in Beta-cells" Cell Signaling Group Lecture Series; University at Buffalo (2003)
- "Hypothyroidism in the Pediatric Population: A Review - 10 Year Old Male with Profound Growth Failure" Pediatric Resident Case Conference; Women and Children‘s Hospital of Buffalo (2003)
- "Sphingosine 1-Phosphate Signaling and Beta-cell Survival" International Diabetes Federation Congress; International Diabetes Federation (2003)
- "Characterization of Sphingosine 1-Phosphate Production in Pancreatic Islets" Endocrine Fellows Forum; Endocrine Fellows Foundation (2003)
- "Cytokine-mediated Activation of a Novel Sphingolipid Pathway in Pancreatic Islets" Drug Research Symposium; University at Buffalo (2003)
- "EDG Receptors, Sphingosine 1-Phosphate and Apoptosis" Study Group Meeting; European Association for the Study of Diabetes (2003)
- "Idiopathic Hypercalcemia in an Infant Girl, Resolving Spontaneously After Three Months of Furosemide Treatment" ENDO 2003; Endocrine Society (2003)
- "Cytokine-mediated Activation of a Novel Sphingolipid Pathway in Pancreatic Islets" Cytokine Symposium: Translation Possibilities and Realities; University at Buffalo (2003)
- "Calcium Metabolism and Homeostasis - 2 Year Old Male with ‘Claw Hands‘" Pediatric Resident Case Conference; Women and Children‘s Hospital of Buffalo (2002)
- "E3-mediated Assembly of Unanchored Polyubiquitin Chains" Summer Research Conference: Ubiquitin and Protein Degradations; FASEB (1997)
- "A Single Amino Acid Substitution in the Ubiquitin Conjugating Enzyme E2-25K Abolishes Activity in Conjugation" 9th Annual Buffalo Conference for Microbial Pathogenesis; The Witebsky Center for Microbial Pathogenesis and Immunology (1997)
- "A Ubiquitin Conjugating Enzyme Transiently Induced During Terminal Erythoid Differentiation" Annual Meeting; American Society for Biochemistry and Molecular Biology (1994)
- "Schwann Cells Release Both Plasminogen Activator and Plasminogen Activator Inhibitor" Journal of Cell Biology Annual Conference; The Rockefeller University (1989)
Service Activities:
- American Academy of Pediatrics, Section on Endocrinology, Chair Elect; Chair Elect (2023–present)
- Endocrine Society Annual Meeting, 2023 Abstract Reviewer; Abstract Review (2023)
- Pediatric Endocrine Society, Abstract Reviewer, Annual Meeting 2023; Abstract Reviewer (2023)
- Research Faculty Member, Anaesthesiology T32 Training Grant Submission (2023–present)
- Pediatrics; Manuscript Review (2023–present)
- Panel Member, Students Interested in Pediatrics; Panel Member (2022)
- Moonlighting Policy Development (2022)
- T32 Anesthesia Research Training Grant; Research Mentor (2022)
- JSMBS Strategic Planning Research; Clinical Research; Contributor (2022)
- Joint Statement regarding thyroid dysfunction after iodinated contrast. AAP, Section on Endocrinology Member; Contributor to development of manuscript and reviewer (2022)
- Jacobs School of Medicine and Biomedical Sciences, Research Focus Group; Discussant (2022)
- Pediatric Endocrine Society Annual Meeting 2022, Abstract submission rating and review; Abstract Review (2022)
- Endocrine Society Annual Meeting, 2022, Abstract submission rating and review; Abstract Review (2022)
- Interview Pediatric Residents; Match committee; Interviewer (2022)
- Clinical Mentor Lead; MD-PhD Program Steering Committee (2022)
- Office of Professional Medical Conduct; Member Medical Expert Program (2022)
- Pediatric Residency Core Competency Committee, Mentor for 3 pediatric residents per academic year; Member/Mentor (2022)
- Responsible for reviewing Case reports submitted by MS3 students during their clinical clerkship. Review 2 cases/3 students/6 week module; Pediatric Clerkship -- Case Report Reviewer (2022)
- AAP Female Leadership and Excellence in Subspecialty Pediatrics group; Pediatric Endocrinology AAP (2022)
- Peer Review of manuscripts submitted to Pediatrics; Reviewer (2022)
- Review, score, and study section meeting for 2022 KL2 Application from the Pennsylvania State University Clinical and Translational Science. Coordination with UB CTSI; Grant Review (2022)
- Pediatric Endocrine Society 2022 Meeting, Selection for Leona Cutler Quality Improvement Award; Selection Chair (2022)
- Health Sciences Institutional Review Board; Member (2022–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council; Member (2019–2021)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Residency Program - Professional Development Task Force Faculty Leader (2019–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Divij Pasrija); Committee Member (2019–present)
- UBMD Physicians‘ Group: Cerner Optimization and Implementation Physician Champion (2018–present)
- American Academy of Pediatrics: Section on Endocrinology Executive Committee; Committee Member (2018–present)
- Pediatric Diabetes Consortium: Protocol Development Committee; Committee Member (2018–present)
- Pediatric Diabetes Consortium: Operations Committee; Committee Member (2018–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Search Committee for Department Chair of Pediatrics; Committee Member (2017–2018)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatrics Scientific Review Committee; Committee Member (2017–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: CTRC Pharmacy Standard Operating Procedure Study Drug Dispensing Policy; Advisor (2017)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Lina Saadeh); Committee Member (2017–2019)
- Pediatric Diabetes Consortium: Oversight Committee - Astrazeneca Dapagliflozin Study; Consultant (2017–present)
- Sanofi: Toujeo; Consultant (2016–present)
- JAEB Center for Health Research Foundation, Inc.: Pediatric Diabetes Consortium - Oversight Committee; Committee Member (2016–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Leena Mamilly); Committee Member (2016–2018)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Ahmad Al Dughiem); Committee Member (2016–2018)
- Kaleida Health: Medical Executive Committee; Committee Member (2016–2020)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Teaching Interest Group (Pediatrics); Member (2016–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Students Interested in Pediatrics Group Faculty Facilitator (2016–present)
- 2016 Pediatric Academic Societies: Annual Meeting Abstracts; Ad Hoc Reviewer (2015)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Shilpa Kumta); Committee Member (2015–2018)
- American Medical Women‘s Association: Alumni Women in Medicine - University at Buffalo Chapter; Panel Member (2015)
- Camp Onyasha: Medical Advisory Board; Board Member (2015–present)
- Immunological Investigations: Editorial Review Board; Board Member (2015–present)
- Journal of Peridontology; Ad Hoc Reviewer (2015–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Adrian Chapa); Committee Member (2015–2016)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: 18th Annual Scholarly Exchange Day Faculty Facilitator and Poster Judge (2015)
- UBMD Pediatrics: Benefits Committee; Committee Member (2015–2017)
- University at Buffalo: Institutional Review Board Responsible for review and approval of research proposals and clinical trials performed at UB with the goal of ensuring the rights and well-being of human subjects.; Member (2014–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Rajeev Thirunagari); Committee Member (2014–2016)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Colleen Nugent); Committee Member (2013–2015)
- American Medical Women‘s Association: University at Buffalo Chapter; Advisor (2013–present)
- PLoS ONE; Ad Hoc Reviewer (2013–present)
- PREP Endocrinology Editorial Board Writer and Contributor (2013–2018)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: CTRC Curriculum Development Committee; Committee Member (2012–2015)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Waleed Janem); Committee Member (2012–2015)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council Steering Committee; Committee Member (2012–2014)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Angela Mojica); Committee Member (2012–2014)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Library Work Group - Program Planning; Member (2012)
- Case Reports in Endocrinology: Editorial Review Board; Board Member (2012–present)
- Hindawi Press; Editorial Board Member (2012–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: 15th Annual Scholarly Exchange Day Facilitator and Poster Judge (2012)
- University at Buffalo: Children and Youth Institutional Review Board Responsible for review of all proposals for investigational drug use in pediatric patients; Consultant (2012–2014)
- Case Reports in Endocrinology; Ad Hoc Reviewer (2012–present)
- American Diabetes Association: Camp Aspire Medical Advisory Board; Board Member (2012–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Sfurti Nath); Committee Member (2011–2013)
- Women and Children‘s Hospital of Buffalo: Pediatric Pharmacy and Therapeutics Subcommittee Contributed expert opinion regarding insulin analogs to be recommended for hospital formulary.; Contributor (2011)
- Diabetes Management; Ad Hoc Reviewer (2011–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Jyostna Rao); Committee Member (2011–2014)
- Dove Medical Press; Ad Hoc Reviewer (2011–present)
- Pediatric Endocrine Society: Education Council; Member (2011–2014)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Sonal Desai); Committee Member (2011–2012)
- Pediatric Endocrine Society: Fellow Education Subcommittee; Committee Member (2011–present)
- University at Buffalo School of Social and Preventive Medicine: Master‘s Thesis Committee Mahrin Kader, MPH (Masters Candidate): "A lifestyle weight loss intervention among severly obese patients and its impact on structural and functional subclinical CVD: A clinical trial."; Committee Member (2010–2012)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Master's Thesis Committee (Mahrin Kader); Committee Member (2010–2012)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Resident Recruitment Committee; Committee Member (2010–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Anju Sukamaran); Committee Member (2010–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Raza Patel); Committee Member (2010–2011)
- Journal of Endocrinology; Ad Hoc Reviewer (2010–present)
- D-Link: Diabetes Support Group; Advisor (2010–present)
- Journal of Clinical Medicine and Research; Ad Hoc Reviewer (2010–present)
- Diabetologia; Ad Hoc Reviewer (2010–present)
- Diabetes Action Research and Education Foundation: Medical Advisory Board; Board Member (2010–present)
- Medical Principles and Practice; Ad Hoc Reviewer (2009–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Admissions Committee; Committee Member (2009–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Medical Scientist Training Program Admissions Committee; Committee Member (2009–present)
- Western New York Juvenile Diabetes Research Foundation: Research Information Volunteer; Chair (2009–present)
- Diabetes Technology and Therapeutics; Ad Hoc Reviewer (2009–present)
- McMaster On-Line Rating of Evidence; Ad Hoc Reviewer (2009–present)
- Immunological Investigations; Ad Hoc Reviewer (2008–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Indrajit Majumdar); Committee Member (2008–2011)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: 11th Annual Scholarly Exchange Day Facilitator and Poster Judge (2008)
- Western New York Juvenile Diabetes Research Foundation: Outreach and Education Committee; Committee Member (2008–2011)
- University at Buffalo: Radiation Safety Committee; Committee Member (2007–2019)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Nadia Danilovich); Committee Member (2007–2010)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Endocrinology Journal Club; Coordinator (2007–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Maala Daniel); Committee Member (2007–2009)
- Eli Lilly Speaker‘s Bureau: Growth Hormone Use, Pediatric Growth Disorders, Genetics of Human Growth; Member (2007–2009)
- University at Buffalo: Faculty Senate; Member (2006–2012)
- Western New York Juvenile Diabetes Research Foundation; Board Member (2006–2011)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Sudha Garimella); Committee Member (2006–2008)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: 9th Annual Scholarly Exchange Day Facilitator and Poster Judge (2006)
- Lawson Wilkins Pediatric Endocrine Society/Society for Pediatric Research: Annual Meeting Abstracts; Reviewer (2005)
- Pediatric Diabetes; Ad Hoc Reviewer (2005–present)
- University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scholarly Oversight Committee (Anshu Gupta); Committee Member (2005–2007)
- Lawson Wilkins Pediatric Endocrine Society/Eastern Society for Pediatric Endocrinology: Annual Meeting Abstracts; Reviewer (2005)
- Women and Children‘s Hospital of Buffalo: Investigational Drug Use Committee Responsible for review of proposals for investigational drug use in pediatric patients (Subcommittee of Institutional Review Board).; Committee Member (2005–2011)
- Lipids; Ad Hoc Reviewer (2005–present)
- Camp Onyasha Diabetes Camp; Medical Director/Advisor
- American Diabetes Camp: Medical Team (2006, 2007, 2010, 2012); Member
- Make-A-Wish Foundation of Western New York: Medical Advisory Council; Member